♥
ISIN : INE741K01010
NSE : CREDITACC
BSE : 541770
Face Value : 10
Industry : Finance - NBFC
EPS : 90.41
EPS (TTM) : 83.27
Price to Earning (P/E) : 10.53
Book Value : 410.27
Price to Bookvalue (P/B) : 2.32
Dividend Yield : 1 %
Return on Equity (ROE) : 24.87 %
Return on Capital Employed (ROCE) : 14.76 %
CREDITACCESS GRAMEEN LIMITED
ISIN : INE741K01010
NSE : CREDITACC
BSE : 541770
Face Value : 10
Industry : Finance - NBFC
EPS : 90.41
EPS (TTM) : 83.27
Price to Earning (P/E) : 10.53
Book Value : 410.27
Price to Bookvalue (P/B) : 2.32
Dividend Yield : 1 %
Return on Equity (ROE) : 24.87 %
Return on Capital Employed (ROCE) : 14.76 %
CREDITACCESS GRAMEEN share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 1166.6 - 1179.55 1.1 % |
| Low / High | 1157.35 - 1186.75 2.5 % |
| Trade Volume | 6,144 |
| 52 Week Low / High | 1066.5 - 1496.6 40.3 % |
-
YOU MAY ALSO LIKE
- Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Share Market basics for beginners
Share Market jargons in simple terms - Stock market course tutorial
Stock Market Investment Course explained in simple words.
CONSOLIDATED QUARTERLY RESULT FOR CREDITACCESS GRAMEEN LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 7595.9 | 8122.2 | 9079 | 10654.1 | 11700.3 | 12469.4 | 12922 | 14574.9 | 15120.3 | 14532.9 |
| Total Income | 7605.2 | 8143.1 | 9097.2 | 10662.4 | 11707.2 | 12475.9 | 12952.3 | 14591 | 15125.8 | 14539.2 |
| Total Expenditure | 2799.9 | 2992.5 | 2928.7 | 3105.6 | 3063.7 | 3446.7 | 3651 | 4337.4 | 4531.8 | 7001.4 |
| Other Income | 9.3 | 20.9 | 18.2 | 8.3 | 6.9 | 6.5 | 30.3 | 16.1 | 5.5 | 6.3 |
| Operating Profit | 4805.3 | 5150.6 | 6168.5 | 7556.8 | 8643.5 | 9029.2 | 9301.3 | 10253.6 | 10594 | 7537.8 |
| Interest | 2798 | 2732.3 | 3142.1 | 3456.4 | 3849.2 | 4238.7 | 4415 | 4821.5 | 5103.1 | 4846 |
| PBDT | 2007.3 | 2418.3 | 3026.4 | 4100.4 | 4794.3 | 4790.5 | 4886.3 | 5432.1 | 5490.9 | 2691.8 |
| Depreciation | 119.2 | 128.2 | 126.1 | 124.9 | 120.6 | 122.8 | 130.6 | 137.5 | 143.5 | 171.9 |
| Profit Before Tax | 1888.1 | 2290.1 | 2900.3 | 3975.5 | 4673.7 | 4667.7 | 4755.7 | 5294.6 | 5347.4 | 2519.9 |
| Tax | 492.5 | 528.6 | 732.8 | 1009.8 | 1189.1 | 1197.3 | 1222.3 | 1323.8 | 1370.8 | 659.3 |
| Profit After Tax | 1395.6 | 1761.5 | 2167.5 | 2965.7 | 3484.6 | 3470.4 | 3533.4 | 3970.8 | 3976.6 | 1860.6 |
| Net Profit | 1395.6 | 1761.5 | 2167.5 | 2965.7 | 3484.6 | 3470.4 | 3533.4 | 3970.8 | 3976.6 | 1860.6 |
| Equity Capital | 1559.3 | 1561.1 | 1561.7 | 1589.1 | 1589.3 | 1591.1 | 1591.8 | 1593.8 | 1594.1 | 1594.6 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 8.84 | 11.02 | 13.59 | 18.66 | 21.93 | 21.81 | 22.2 | 24.91 | 24.95 | 11.67 |
| Diluted Eps After Extraordinary Items | 8.8 | 10.97 | 13.53 | 18.59 | 21.8 | 21.69 | 22.05 | 24.79 | 24.82 | 11.61 |
| Diluted Eps Before Extraordinary Items | 8.8 | 10.97 | 13.53 | 18.59 | 21.8 | 21.69 | 22.05 | 24.79 | 24.82 | 11.61 |
STANDALONE QUARTERLY RESULT FOR CREDITACCESS GRAMEEN LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 6207.6 | 6714.3 | 7588.5 | 10654.1 | 11700.3 | 12469.4 | 12922 | 14574.9 | 15120.3 | 14532.9 |
| Total Income | 6212.6 | 6722.1 | 7594.4 | 10662.2 | 11707.2 | 12475.9 | 12952.3 | 14591 | 15125.8 | 14539.2 |
| Total Expenditure | 2094.4 | 2364.7 | 2284.5 | 3105.6 | 3085.4 | 3425 | 3650.2 | 4338.3 | 4531.8 | 7001.4 |
| Other Income | 5 | 7.8 | 5.9 | 8.1 | 6.9 | 6.5 | 30.3 | 16.1 | 5.5 | 6.3 |
| Operating Profit | 4118.2 | 4357.4 | 5309.9 | 7556.6 | 8621.8 | 9050.9 | 9302.1 | 10252.7 | 10594 | 7537.8 |
| Interest | 2256.4 | 2212.6 | 2587.1 | 3456.4 | 3849.2 | 4238.7 | 4415 | 4821.5 | 5103.1 | 4846 |
| PBDT | 1861.8 | 2144.8 | 2722.8 | 4100.2 | 4772.6 | 4812.2 | 4887.1 | 5431.2 | 5490.9 | 2691.8 |
| Depreciation | 68.4 | 79.2 | 78 | 124.9 | 120.6 | 122.8 | 130.6 | 137.5 | 143.5 | 171.9 |
| Profit Before Tax | 1793.4 | 2065.6 | 2644.8 | 3975.3 | 4652 | 4689.4 | 4756.5 | 5293.7 | 5347.4 | 2519.9 |
| Tax | 467.6 | 478.5 | 670.6 | 1009.8 | 1189.1 | 1197.3 | 1222.3 | 1323.8 | 1370.8 | 659.3 |
| Profit After Tax | 1325.8 | 1587.1 | 1974.2 | 2965.5 | 3462.9 | 3492.1 | 3534.2 | 3969.9 | 3976.6 | 1860.6 |
| Net Profit | 1325.8 | 1587.1 | 1974.2 | 2965.5 | 3462.9 | 3492.1 | 3534.2 | 3969.9 | 3976.6 | 1860.6 |
| Equity Capital | 1559.3 | 1561.1 | 1561.7 | 1589.1 | 1589.3 | 1591.1 | 1591.8 | 1593.8 | 1594.1 | 1594.6 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 8.5 | 10.17 | 12.64 | 18.66 | 21.79 | 21.95 | 22.2 | 24.91 | 24.95 | 11.67 |
| Diluted Eps After Extraordinary Items | 8.46 | 10.12 | 12.59 | 18.59 | 21.67 | 21.82 | 22.06 | 24.78 | 24.82 | 11.61 |
| Diluted Eps Before Extraordinary Items | 8.46 | 10.12 | 12.59 | 18.59 | 21.67 | 21.82 | 22.06 | 24.78 | 24.82 | 11.61 |
CONSOLIDATED ANNUAL RESULT FOR CREDITACCESS GRAMEEN LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 27428.2 | 35451.2 | 51666.7 |
| Total Income | 27501.3 | 35507.9 | 51726.5 |
| Total Expenditure | 12379.7 | 11826.5 | 14498.8 |
| Other Income | 73.1 | 56.7 | 59.8 |
| Operating Profit | 15121.6 | 23681.4 | 37227.7 |
| Interest | 9841.4 | 12128.8 | 17324.4 |
| PBDT | 5280.2 | 11552.6 | 19903.3 |
| Depreciation | 472.3 | 498.4 | 511.5 |
| Profit Before Tax | 4807.9 | 11054.2 | 19391.8 |
| Tax | 1236.9 | 2793.6 | 4932.5 |
| Profit After Tax | 3571 | 8260.6 | 14459.3 |
| Net Profit | 3571 | 8260.6 | 14459.3 |
| Equity Capital | 1558.7 | 1589.1 | 1593.8 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 38217.8 | 49480.6 | 64106 |
| Calculated EPS | 23.29 | 51.98 | 90.72 |
| Diluted Eps After Extraordinary Items | 23.22 | 51.82 | 90.41 |
| Diluted Eps Before Extraordinary Items | 23.22 | 51.82 | 90.41 |
STANDALONE ANNUAL RESULT FOR CREDITACCESS GRAMEEN LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 22893.9 | 35451.2 | 51666.7 |
| Total Income | 22912 | 35507.6 | 51726.5 |
| Total Expenditure | 9642 | 11826.5 | 14498.8 |
| Other Income | 18.1 | 56.4 | 59.8 |
| Operating Profit | 13270 | 23681.1 | 37227.7 |
| Interest | 7881.3 | 12128.8 | 17324.4 |
| PBDT | 5388.7 | 11552.3 | 19903.3 |
| Depreciation | 262.3 | 498.4 | 511.5 |
| Profit Before Tax | 5126.4 | 11053.9 | 19391.8 |
| Tax | 1305 | 2793.6 | 4932.5 |
| Profit After Tax | 3821.4 | 8260.3 | 14459.3 |
| Net Profit | 3821.4 | 8260.3 | 14459.3 |
| Equity Capital | 1558.7 | 1589.1 | 1593.8 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 37839.3 | 49480.3 | 64105.7 |
| Calculated EPS | 24.52 | 51.98 | 90.72 |
| Diluted Eps After Extraordinary Items | 24.44 | 51.81 | 90.41 |
| Diluted Eps Before Extraordinary Items | 24.44 | 51.81 | 90.41 |
CONSOLIDATED PROFIT / LOSS FOR CREDITACCESS GRAMEEN LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 2460.74 Cr | 2742.82 Cr | 3545.12 Cr | 5166.67 Cr |
| Interest income | 2290.03 Cr | 2567.33 Cr | 3327.12 Cr | 4900.11 Cr |
| Processing fees and other charges | 8.5 Cr | 13.22 Cr | 19.52 Cr | 92.42 Cr |
| Operating Income (Net) | 2460.74 Cr | 2742.82 Cr | 3545.12 Cr | 5166.67 Cr |
| Employee Cost | 379.99 Cr | 437.66 Cr | 515.24 Cr | 669.43 Cr |
| Salaries, Wages & Bonus | 340.21 Cr | 388.2 Cr | 454.28 Cr | 588.58 Cr |
| Contributions to EPF & Pension Funds | 35.37 Cr | 40.26 Cr | 45.33 Cr | 61.72 Cr |
| Workmen and Staff Welfare Expenses | 2.45 Cr | 3.75 Cr | 4.98 Cr | 2.42 Cr |
| Operating & Establishment Expenses | 45.92 Cr | 62.34 Cr | 74.34 Cr | 103.97 Cr |
| Commission, Brokerage & Discounts | 3.01 Cr | 2.96 Cr | 1.8 Cr | 3.9 Cr |
| Rent , Rates & Taxes | 26.9 Cr | 33.15 Cr | 41.71 Cr | 46.06 Cr |
| Repairs and Maintenance | 10.68 Cr | 18.41 Cr | 19.46 Cr | 39.24 Cr |
| Insurance | 1.86 Cr | 3.59 Cr | 5.94 Cr | 8.09 Cr |
| Electricity & Power | 3.47 Cr | 4.23 Cr | 5.43 Cr | 6.68 Cr |
| Administrations & Other Expenses | 91.01 Cr | 117.97 Cr | 161.54 Cr | 198.66 Cr |
| Printing and stationery | 6.3 Cr | 6.2 Cr | 6.15 Cr | 10.59 Cr |
| Professional and legal fees | 16.99 Cr | 17.2 Cr | 23.15 Cr | 31.44 Cr |
| Provisions and Contingencies | 791.37 Cr | 616.72 Cr | 428.29 Cr | 471.9 Cr |
| Loss on foreign exchange fluctuations | 1 Lk | 0 | 0 | 0 |
| Total Expenditure | 1308.29 Cr | 1234.69 Cr | 1179.41 Cr | 1443.96 Cr |
| Other Income | 5.34 Cr | 7.31 Cr | 5.67 Cr | 5.98 Cr |
| Operating Profit | 1157.79 Cr | 1515.44 Cr | 2371.38 Cr | 3728.69 Cr |
| Interest | 933.32 Cr | 987.42 Cr | 1216.12 Cr | 1738.36 Cr |
| Loans | 773.61 Cr | 797.46 Cr | 1054.17 Cr | 1509.12 Cr |
| Bonds / Debentures | 142.39 Cr | 176.71 Cr | 146.91 Cr | 207.32 Cr |
| Depreciation | 44.07 Cr | 47.23 Cr | 49.84 Cr | 51.15 Cr |
| Profit Before Taxation & Exceptional Items | 180.4 Cr | 480.79 Cr | 1105.42 Cr | 1939.18 Cr |
| Profit Before Tax | 180.4 Cr | 480.79 Cr | 1105.42 Cr | 1939.18 Cr |
| Provision for Tax | 49 Cr | 123.69 Cr | 279.36 Cr | 493.25 Cr |
| Current Income Tax | 106.44 Cr | 121.78 Cr | 238.23 Cr | 543.96 Cr |
| Deferred Tax | -57.44 Cr | 1.3 Cr | 41.13 Cr | -51.32 Cr |
| Profit After Tax | 131.4 Cr | 357.1 Cr | 826.06 Cr | 1445.93 Cr |
| Minority Interest | 2.62 Cr | 5.94 Cr | 0 | 0 |
| Consolidated Net Profit | 134.02 Cr | 363.04 Cr | 826.06 Cr | 1445.93 Cr |
| Profit Balance B/F | 818.53 Cr | 924.22 Cr | 1194.73 Cr | 1855.13 Cr |
| Appropriations | 952.55 Cr | 1287.26 Cr | 2020.79 Cr | 3301.06 Cr |
| Equity Dividend % | 0 | 0 | 0 | 100 |
| Earnings Per Share | 8.61 | 23.29 | 51.98 | 90.72 |
| Adjusted EPS | 8.61 | 23.29 | 51.98 | 90.72 |
STANDALONE PROFIT / LOSS FOR CREDITACCESS GRAMEEN LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 2027.53 Cr | 2289.39 Cr | 3545.12 Cr | 5166.67 Cr |
| Interest income | 1877.13 Cr | 2124.79 Cr | 3327.13 Cr | 4900.11 Cr |
| Processing fees and other charges | 8.49 Cr | 13.22 Cr | 19.51 Cr | 92.42 Cr |
| Operating Income (Net) | 2027.53 Cr | 2289.39 Cr | 3545.12 Cr | 5166.67 Cr |
| Employee Cost | 299.6 Cr | 353.5 Cr | 515.24 Cr | 669.43 Cr |
| Salaries, Wages & Bonus | 269.69 Cr | 314.83 Cr | 453.37 Cr | 588.58 Cr |
| Contributions to EPF & Pension Funds | 26.33 Cr | 31.51 Cr | 46.24 Cr | 61.72 Cr |
| Workmen and Staff Welfare Expenses | 1.62 Cr | 1.71 Cr | 4.98 Cr | 2.42 Cr |
| Operating & Establishment Expenses | 37.33 Cr | 50.23 Cr | 74.34 Cr | 103.97 Cr |
| Commission, Brokerage & Discounts | 3.01 Cr | 2.96 Cr | 1.8 Cr | 3.9 Cr |
| Rent , Rates & Taxes | 22.43 Cr | 27.93 Cr | 41.71 Cr | 46.06 Cr |
| Repairs and Maintenance | 7.15 Cr | 12.39 Cr | 19.46 Cr | 39.24 Cr |
| Insurance | 1.75 Cr | 3.41 Cr | 5.94 Cr | 8.09 Cr |
| Electricity & Power | 2.99 Cr | 3.54 Cr | 5.43 Cr | 6.68 Cr |
| Administrations & Other Expenses | 69.67 Cr | 93.68 Cr | 161.54 Cr | 198.66 Cr |
| Printing and stationery | 4.87 Cr | 4.34 Cr | 6.15 Cr | 10.59 Cr |
| Professional and legal fees | 9.64 Cr | 12.82 Cr | 23.15 Cr | 31.44 Cr |
| Provisions and Contingencies | 662.16 Cr | 463.51 Cr | 428.29 Cr | 471.9 Cr |
| Loss on foreign exchange fluctuations | 1 Lk | 0 | 0 | 0 |
| Total Expenditure | 1068.76 Cr | 960.92 Cr | 1179.41 Cr | 1443.96 Cr |
| Other Income | 3.62 Cr | 1.81 Cr | 5.64 Cr | 5.98 Cr |
| Operating Profit | 962.39 Cr | 1330.28 Cr | 2371.35 Cr | 3728.69 Cr |
| Interest | 744.67 Cr | 791.41 Cr | 1216.12 Cr | 1738.36 Cr |
| Loans | 618.56 Cr | 626.44 Cr | 1054.17 Cr | 1509.12 Cr |
| Bonds / Debentures | 114.52 Cr | 153.63 Cr | 146.91 Cr | 207.32 Cr |
| Depreciation | 23.43 Cr | 26.23 Cr | 49.84 Cr | 51.15 Cr |
| Profit Before Taxation & Exceptional Items | 194.29 Cr | 512.64 Cr | 1105.39 Cr | 1939.18 Cr |
| Profit Before Tax | 194.29 Cr | 512.64 Cr | 1105.39 Cr | 1939.18 Cr |
| Provision for Tax | 51.9 Cr | 130.5 Cr | 279.36 Cr | 493.25 Cr |
| Current Income Tax | 93.44 Cr | 113.56 Cr | 238.23 Cr | 543.97 Cr |
| Deferred Tax | -41.54 Cr | 16.94 Cr | 41.13 Cr | -51.32 Cr |
| Profit After Tax | 142.39 Cr | 382.14 Cr | 826.03 Cr | 1445.93 Cr |
| Consolidated Net Profit | 142.39 Cr | 382.14 Cr | 826.03 Cr | 1445.93 Cr |
| Profit Balance B/F | 815.59 Cr | 929.68 Cr | 1194.73 Cr | 1855.1 Cr |
| Appropriations | 957.98 Cr | 1311.82 Cr | 2020.76 Cr | 3301.03 Cr |
| Equity Dividend % | 0 | 0 | 0 | 100 |
| Earnings Per Share | 9.15 | 24.52 | 51.98 | 90.72 |
| Adjusted EPS | 9.15 | 24.52 | 51.98 | 90.72 |
CONSOLIDATED CASH FLOW FOR CREDITACCESS GRAMEEN LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 180.4 Cr | 480.79 Cr | 1105.42 Cr | 1939.18 Cr |
| Adjustment | 652.79 Cr | 555.62 Cr | 386.62 Cr | 341.59 Cr |
| Changes In working Capital | -1172.64 Cr | -3630.43 Cr | -4541.73 Cr | -6453.62 Cr |
| Cash Flow after changes in Working Capital | -339.45 Cr | -2594.02 Cr | -3049.69 Cr | -4172.85 Cr |
| Cash Flow from Operating Activities | -454.67 Cr | -2714.34 Cr | -3289.78 Cr | -4733.78 Cr |
| Cash Flow from Investing Activities | 23.53 Cr | -32.96 Cr | -314.43 Cr | -994.2 Cr |
| Cash Flow from Financing Activitie | 2146.36 Cr | 1967.76 Cr | 3365.07 Cr | 5493.86 Cr |
| Net Cash Inflow / Outflow | 1715.22 Cr | -779.54 Cr | -239.14 Cr | -234.12 Cr |
| Opening Cash & Cash Equivalents | 644.87 Cr | 2360.09 Cr | 1580.55 Cr | 1341.41 Cr |
| Closing Cash & Cash Equivalent | 2360.09 Cr | 1580.55 Cr | 1341.41 Cr | 1107.29 Cr |
STANDALONE CASH FLOW FOR CREDITACCESS GRAMEEN LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 194.29 Cr | 512.64 Cr | 1105.39 Cr | 1939.18 Cr |
| Adjustment | 547.91 Cr | 380.58 Cr | 386.63 Cr | 341.59 Cr |
| Changes In working Capital | -1001.15 Cr | -2749.27 Cr | -4541.71 Cr | -6453.72 Cr |
| Cash Flow after changes in Working Capital | -258.95 Cr | -1856.05 Cr | -3049.69 Cr | -4172.95 Cr |
| Cash Flow from Operating Activities | -364.32 Cr | -1968.56 Cr | -3289.76 Cr | -4733.89 Cr |
| Cash Flow from Investing Activities | -31.67 Cr | -189.25 Cr | -314.42 Cr | -994.2 Cr |
| Cash Flow from Financing Activitie | 1705.96 Cr | 1684.38 Cr | 3365.07 Cr | 5493.86 Cr |
| Net Cash Inflow / Outflow | 1309.97 Cr | -473.43 Cr | -239.11 Cr | -234.23 Cr |
| Opening Cash & Cash Equivalents | 564.62 Cr | 1874.59 Cr | 1580.51 Cr | 1341.4 Cr |
| Closing Cash & Cash Equivalent | 1874.59 Cr | 1401.16 Cr | 1341.4 Cr | 1107.17 Cr |
CONSOLIDATED BALANCE SHEET FOR CREDITACCESS GRAMEEN LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 155.58 Cr | 155.87 Cr | 158.91 Cr | 159.38 Cr |
| Equity - Authorised | 160 Cr | 160 Cr | 160 Cr | 170 Cr |
| Equity - Issued | 155.58 Cr | 155.87 Cr | 158.91 Cr | 159.38 Cr |
| Equity Paid Up | 155.58 Cr | 155.87 Cr | 158.91 Cr | 159.38 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 3527.45 Cr | 3810.06 Cr | 4928.65 Cr | 6379.43 Cr |
| Securities Premium | 2263.13 Cr | 2268.12 Cr | 2478.59 Cr | 2498.13 Cr |
| Capital Reserves | 49.95 Cr | 49.95 Cr | 49.95 Cr | 49.95 Cr |
| Profit & Loss Account Balance | 924.22 Cr | 1211.3 Cr | 1855.13 Cr | 3011.07 Cr |
| Reserve excluding Revaluation Reserve | 3527.45 Cr | 3810.06 Cr | 4928.65 Cr | 6379.43 Cr |
| Shareholder's Funds | 3691.55 Cr | 3977.65 Cr | 5106.97 Cr | 6569.98 Cr |
| Minority Interest | 104.83 Cr | 98.4 Cr | 0 | 0 |
| Secured Loans | 10773.5 Cr | 12710.2 Cr | 16009.7 Cr | 21665.5 Cr |
| Non Convertible Debentures | 1659.94 Cr | 1418.1 Cr | 1672.35 Cr | 2042.12 Cr |
| Term Loans - Banks | 6256.24 Cr | 8697.44 Cr | 10740.3 Cr | 13005 Cr |
| Term Loans - Institutions | 2622.65 Cr | 2500.89 Cr | 2123.22 Cr | 3059.6 Cr |
| Unsecured Loans | 167.82 Cr | 210.52 Cr | 277.33 Cr | 150.28 Cr |
| Long Term Loan in Foreign Currency | 0 | 116.08 Cr | 125.88 Cr | 128.07 Cr |
| Loans - Banks | 0 | 0 | 98.8 Cr | 22.21 Cr |
| Loans - Others | 50.11 Cr | 16.7 Cr | 0 | 0 |
| Deferred Tax Assets / Liabilities | -104.09 Cr | -132.48 Cr | -80.93 Cr | -136.92 Cr |
| Deferred Tax Assets | 160.43 Cr | 183.96 Cr | 112.48 Cr | 157.76 Cr |
| Deferred Tax Liability | 56.34 Cr | 51.48 Cr | 31.55 Cr | 20.84 Cr |
| Other Long Term Liabilities | 0 | 0 | 0 | 87.81 Cr |
| Long Term Provisions | 572.66 Cr | 462.96 Cr | 528.84 Cr | 1315.9 Cr |
| Total Non-Current Liabilities | 11409.9 Cr | 13251.2 Cr | 16734.9 Cr | 23082.6 Cr |
| Trade Payables | 201.69 Cr | 259.02 Cr | 303.7 Cr | 256.35 Cr |
| Sundry Creditors | 201.69 Cr | 259.02 Cr | 303.7 Cr | 256.35 Cr |
| Other Current Liabilities | 94.31 Cr | 102.62 Cr | 97.98 Cr | 43.55 Cr |
| Short Term Borrowings | 0 | 0 | 25.26 Cr | 25.24 Cr |
| Short Term Provisions | 17.97 Cr | 208.4 Cr | 264.54 Cr | 32.32 Cr |
| Provision for Tax | 0 | 185.65 Cr | 238.48 Cr | 0 |
| Total Current Liabilities | 313.97 Cr | 570.04 Cr | 691.48 Cr | 357.46 Cr |
| Total Liabilities | 15520.2 Cr | 17897.3 Cr | 22533.4 Cr | 30010 Cr |
| Loans (Non - Current Assets) | 11720.5 Cr | 14765.3 Cr | 19043.3 Cr | 25105 Cr |
| Gross Block | 658.44 Cr | 701.47 Cr | 777.54 Cr | 826.14 Cr |
| Less: Accumulated Depreciation | 85.67 Cr | 130.68 Cr | 178.51 Cr | 217.06 Cr |
| Net Block | 572.77 Cr | 570.79 Cr | 599.03 Cr | 609.08 Cr |
| Non Current Investments | 54 Lk | 54 Lk | 454.52 Cr | 54 Lk |
| Long Term Investment | 54 Lk | 54 Lk | 454.52 Cr | 54 Lk |
| Unquoted | 54 Lk | 54 Lk | 454.52 Cr | 54 Lk |
| Long Term Loans & Advances | 597.12 Cr | 486.72 Cr | 557.83 Cr | 1372.01 Cr |
| Other Non Current Assets | 0 | 0 | 14.13 Cr | 0 |
| Total Non-Current Assets | 12891.5 Cr | 15826.5 Cr | 20672.8 Cr | 27091.2 Cr |
| Currents Investments | 0 | 0 | 0 | 1438.36 Cr |
| Quoted | 0 | 0 | 0 | 1438.36 Cr |
| Unquoted | 54 Lk | 54 Lk | 454.52 Cr | 54 Lk |
| Cash and Bank | 2484.38 Cr | 1761.39 Cr | 1436.43 Cr | 1313.91 Cr |
| Cash in hand | 8.24 Cr | 7.58 Cr | 12.43 Cr | 2.75 Cr |
| Balances at Bank | 2476.14 Cr | 1753.81 Cr | 1424 Cr | 1311.16 Cr |
| Other Current Assets | 110.89 Cr | 86.08 Cr | 149.21 Cr | 147.42 Cr |
| Interest accrued and or due on loans | 105.48 Cr | 78.67 Cr | 104.44 Cr | 0 |
| Prepaid Expenses | 5.41 Cr | 7.41 Cr | 13.14 Cr | 18.6 Cr |
| Short Term Loans and Advances | 33.45 Cr | 223.34 Cr | 274.93 Cr | 19.15 Cr |
| Advances recoverable in cash or in kind | 9.97 Cr | 17.4 Cr | 25.37 Cr | 7.22 Cr |
| Advance income tax and TDS | 0 | 180.53 Cr | 237.92 Cr | 0 |
| Total Current Assets | 2628.72 Cr | 2070.81 Cr | 1860.57 Cr | 2918.84 Cr |
| Net Current Assets (Including Current Investments) | 2314.75 Cr | 1500.77 Cr | 1169.09 Cr | 2561.38 Cr |
| Total Assets | 15520.2 Cr | 17897.3 Cr | 22533.4 Cr | 30010 Cr |
| Contingent Liabilities | 36 Lk | 35 Lk | 25 Lk | 4.24 Cr |
| Total Debt | 10941.3 Cr | 12920.7 Cr | 16312.3 Cr | 21841 Cr |
| Book Value | 236.73 | 0 | 320.15 | 410.27 |
| Adjusted Book Value | 236.73 | 254.44 | 320.15 | 410.27 |
STANDALONE BALANCE SHEET FOR CREDITACCESS GRAMEEN LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 155.58 Cr | 155.87 Cr | 158.91 Cr | 159.38 Cr |
| Equity - Authorised | 160 Cr | 160 Cr | 160 Cr | 170 Cr |
| Equity - Issued | 155.58 Cr | 155.87 Cr | 158.91 Cr | 159.38 Cr |
| Equity Paid Up | 155.58 Cr | 155.87 Cr | 158.91 Cr | 159.38 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 3470.71 Cr | 3772.21 Cr | 4928.62 Cr | 6379.4 Cr |
| Securities Premium | 2263.13 Cr | 2268.13 Cr | 2478.59 Cr | 2498.13 Cr |
| Capital Reserves | 49.95 Cr | 49.95 Cr | 49.95 Cr | 49.95 Cr |
| Profit & Loss Account Balance | 929.68 Cr | 1235.64 Cr | 1855.1 Cr | 3011.04 Cr |
| Reserve excluding Revaluation Reserve | 3470.71 Cr | 3772.21 Cr | 4928.62 Cr | 6379.4 Cr |
| Shareholder's Funds | 3634.81 Cr | 3939.8 Cr | 5106.94 Cr | 6569.95 Cr |
| Secured Loans | 8755.72 Cr | 10369 Cr | 16009.7 Cr | 21665.5 Cr |
| Non Convertible Debentures | 1506.04 Cr | 1372.81 Cr | 1672.35 Cr | 2042.12 Cr |
| Term Loans - Banks | 5115.8 Cr | 6869.21 Cr | 10740.3 Cr | 13005 Cr |
| Term Loans - Institutions | 1908.37 Cr | 2033.22 Cr | 2123.22 Cr | 3059.6 Cr |
| Unsecured Loans | 0 | 116.08 Cr | 277.33 Cr | 150.28 Cr |
| Long Term Loan in Foreign Currency | 0 | 116.08 Cr | 125.88 Cr | 128.07 Cr |
| Loans - Banks | 0 | 0 | 98.8 Cr | 22.21 Cr |
| Deferred Tax Assets / Liabilities | -115.01 Cr | -126.3 Cr | -80.93 Cr | -136.92 Cr |
| Deferred Tax Assets | 131.12 Cr | 145.9 Cr | 112.48 Cr | 157.76 Cr |
| Deferred Tax Liability | 16.11 Cr | 19.6 Cr | 31.55 Cr | 20.84 Cr |
| Other Long Term Liabilities | 0 | 0 | 0 | 87.81 Cr |
| Long Term Provisions | 568.31 Cr | 395.3 Cr | 528.83 Cr | 1315.88 Cr |
| Total Non-Current Liabilities | 9209.02 Cr | 10754.1 Cr | 16734.9 Cr | 23082.5 Cr |
| Trade Payables | 170.26 Cr | 243.85 Cr | 303.7 Cr | 256.35 Cr |
| Sundry Creditors | 170.26 Cr | 243.85 Cr | 303.7 Cr | 256.35 Cr |
| Other Current Liabilities | 91.32 Cr | 99.72 Cr | 97.99 Cr | 42.47 Cr |
| Short Term Borrowings | 25 Cr | 0 | 25.26 Cr | 25.24 Cr |
| Short Term Provisions | 15.48 Cr | 134.31 Cr | 264.53 Cr | 32.3 Cr |
| Provision for Tax | 0 | 114.05 Cr | 238.48 Cr | 0 |
| Total Current Liabilities | 302.06 Cr | 477.88 Cr | 691.48 Cr | 356.36 Cr |
| Total Liabilities | 13145.9 Cr | 15171.7 Cr | 22533.3 Cr | 30008.8 Cr |
| Loans (Non - Current Assets) | 9717.82 Cr | 12201.6 Cr | 19043.3 Cr | 25105 Cr |
| Gross Block | 165.57 Cr | 204.9 Cr | 777.52 Cr | 826.12 Cr |
| Less: Accumulated Depreciation | 64.81 Cr | 89.86 Cr | 178.51 Cr | 217.06 Cr |
| Net Block | 100.76 Cr | 115.04 Cr | 599.01 Cr | 609.06 Cr |
| Non Current Investments | 662.93 Cr | 663.49 Cr | 454.53 Cr | 55 Lk |
| Long Term Investment | 662.93 Cr | 663.49 Cr | 454.53 Cr | 55 Lk |
| Unquoted | 662.93 Cr | 663.49 Cr | 454.53 Cr | 55 Lk |
| Long Term Loans & Advances | 594.76 Cr | 420.35 Cr | 557.83 Cr | 1371.01 Cr |
| Other Non Current Assets | 9.68 Cr | 10.36 Cr | 14.13 Cr | 0 |
| Total Non-Current Assets | 11086.6 Cr | 13413.9 Cr | 20672.8 Cr | 27090.2 Cr |
| Currents Investments | 0 | 0 | 0 | 1438.36 Cr |
| Quoted | 0 | 0 | 0 | 1438.36 Cr |
| Unquoted | 662.93 Cr | 663.49 Cr | 454.53 Cr | 55 Lk |
| Cash and Bank | 1945.97 Cr | 1534.32 Cr | 1436.41 Cr | 1313.77 Cr |
| Cash in hand | 7.96 Cr | 6.95 Cr | 12.43 Cr | 2.75 Cr |
| Balances at Bank | 1938.01 Cr | 1527.37 Cr | 1423.98 Cr | 1311.02 Cr |
| Other Current Assets | 96.17 Cr | 85.3 Cr | 149.21 Cr | 147.42 Cr |
| Interest accrued and or due on loans | 90.75 Cr | 77.89 Cr | 104.44 Cr | 0 |
| Prepaid Expenses | 5.42 Cr | 7.41 Cr | 13.14 Cr | 18.6 Cr |
| Short Term Loans and Advances | 17.18 Cr | 138.21 Cr | 274.92 Cr | 19.15 Cr |
| Advances recoverable in cash or in kind | 10.88 Cr | 13.7 Cr | 25.36 Cr | 7.22 Cr |
| Advance income tax and TDS | 0 | 112.49 Cr | 237.92 Cr | 0 |
| Total Current Assets | 2059.32 Cr | 1757.83 Cr | 1860.54 Cr | 2918.7 Cr |
| Net Current Assets (Including Current Investments) | 1757.26 Cr | 1279.95 Cr | 1169.06 Cr | 2562.34 Cr |
| Total Assets | 13145.9 Cr | 15171.7 Cr | 22533.3 Cr | 30008.8 Cr |
| Contingent Liabilities | 11 Lk | 10 Lk | 25 Lk | 4.24 Cr |
| Total Debt | 8780.72 Cr | 10485.1 Cr | 16312.3 Cr | 21841 Cr |
| Book Value | 233.08 | 0 | 320.15 | 410.26 |
| Adjusted Book Value | 233.08 | 252.01 | 320.15 | 410.26 |
FINANCIAL RATIOS (CONSOLIDATED) FOR CREDITACCESS GRAMEEN LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 8.61 | 23.29 | 51.98 | 90.72 |
| CEPS(Rs) | 11.28 | 25.94 | 55.12 | 93.93 |
| DPS(Rs) | 0 | 0 | 0 | 10 |
| Book NAV/Share(Rs) | 236.73 | 254.44 | 320.15 | 410.27 |
| Tax Rate(%) | 27.16 | 25.73 | 25.27 | 25.44 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 46.83 | 54.98 | 66.73 | 72.05 |
| EBIT Margin(%) | 45.26 | 53.53 | 65.49 | 71.18 |
| Pre Tax Margin(%) | 7.33 | 17.53 | 31.18 | 37.53 |
| PAT Margin (%) | 5.34 | 13.02 | 23.3 | 27.99 |
| Cash Profit Margin (%) | 7.13 | 14.74 | 24.71 | 28.98 |
| Performance Ratios | ||||
| ROA(%) | 0.92 | 2.14 | 4.08 | 5.5 |
| ROE(%) | 4.1 | 9.34 | 17.87 | 24.87 |
| ROCE(%) | 8.28 | 9.31 | 12.06 | 14.76 |
| Asset Turnover(x) | 0.17 | 0.16 | 0.18 | 0.2 |
| Sales/Fixed Asset(x) | 3.85 | 4.03 | 4.61 | 6.44 |
| Working Capital/Sales(x) | 1.06 | 1.83 | 3.03 | 2.02 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.26 | 0.25 | 0.22 | 0.16 |
| Payable days | 118.87 | 0 | 0 | 0 |
| Valuation Parameters | ||||
| PER(x) | 77.83 | 36.45 | 17.6 | 15.87 |
| PCE(x) | 59.45 | 32.73 | 16.6 | 15.33 |
| Price/Book(x) | 2.83 | 3.34 | 2.86 | 3.51 |
| Yield(%) | 0 | 0 | 0 | 0.69 |
| EV/Net Sales(x) | 7.68 | 8.89 | 8.3 | 8.41 |
| EV/Core EBITDA(x) | 16.31 | 16.1 | 12.41 | 11.66 |
| EV/EBIT(x) | 16.96 | 16.61 | 12.67 | 11.82 |
| EV/CE(x) | 1.22 | 1.36 | 1.31 | 1.53 |
| M Cap / Sales | 4.24 | 4.83 | 4.1 | 4.44 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 44.38 | 11.45 | 29.25 | 45.74 |
| Core EBITDA Growth(%) | 8.8 | 30.89 | 56.48 | 57.24 |
| EBIT Growth(%) | 6.71 | 31.83 | 58.12 | 58.41 |
| PAT Growth(%) | -60.83 | 171.77 | 133.97 | 75.04 |
| EPS Growth(%) | -62.81 | 170.38 | 129.49 | 74.52 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 2.97 | 3.26 | 3.21 | 3.34 |
| Current Ratio(x) | 8.37 | 3.63 | 2.69 | 8.17 |
| Quick Ratio(x) | 8.37 | 3.63 | 2.69 | 8.17 |
| Interest Cover(x) | 1.19 | 1.49 | 1.91 | 2.12 |
| Total Debt/Mcap(x) | 1.05 | 0.98 | 1.12 | 0.95 |
FINANCIAL RATIOS (STANDALONE) FOR CREDITACCESS GRAMEEN LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 9.15 | 24.52 | 51.98 | 90.72 |
| CEPS(Rs) | 10.66 | 26.2 | 55.12 | 93.93 |
| DPS(Rs) | 0 | 0 | 0 | 10 |
| Book NAV/Share(Rs) | 233.08 | 252.01 | 320.15 | 410.26 |
| Tax Rate(%) | 26.71 | 25.46 | 25.27 | 25.44 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 47.29 | 58.03 | 66.73 | 72.05 |
| EBIT Margin(%) | 46.31 | 56.96 | 65.48 | 71.18 |
| Pre Tax Margin(%) | 9.58 | 22.39 | 31.18 | 37.53 |
| PAT Margin (%) | 7.02 | 16.69 | 23.3 | 27.99 |
| Cash Profit Margin (%) | 8.18 | 17.84 | 24.71 | 28.98 |
| Performance Ratios | ||||
| ROA(%) | 1.18 | 2.7 | 4.08 | 5.5 |
| ROE(%) | 4.53 | 10.12 | 17.87 | 24.87 |
| ROCE(%) | 8.2 | 9.72 | 12.06 | 14.76 |
| Asset Turnover(x) | 0.17 | 0.16 | 0.18 | 0.2 |
| Sales/Fixed Asset(x) | 13.77 | 12.36 | 4.61 | 6.44 |
| Working Capital/Sales(x) | 1.15 | 1.79 | 3.03 | 2.02 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.07 | 0.08 | 0.22 | 0.16 |
| Payable days | 124.75 | 0 | 0 | 0 |
| Valuation Parameters | ||||
| PER(x) | 73.26 | 34.63 | 17.6 | 15.87 |
| PCE(x) | 62.9 | 32.41 | 16.6 | 15.33 |
| Price/Book(x) | 2.88 | 3.37 | 2.86 | 3.51 |
| Yield(%) | 0 | 0 | 0 | 0.69 |
| EV/Net Sales(x) | 8.52 | 9.69 | 8.3 | 8.41 |
| EV/Core EBITDA(x) | 17.94 | 16.68 | 12.41 | 11.66 |
| EV/EBIT(x) | 18.39 | 17.01 | 12.67 | 11.82 |
| EV/CE(x) | 1.31 | 1.46 | 1.31 | 1.53 |
| M Cap / Sales | 5.14 | 5.78 | 4.1 | 4.44 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 20.44 | 12.9 | 29.25 | 45.74 |
| Core EBITDA Growth(%) | -7.94 | 38.23 | 56.48 | 57.24 |
| EBIT Growth(%) | -8.46 | 38.88 | 58.12 | 58.41 |
| PAT Growth(%) | -56.52 | 168.38 | 133.95 | 75.05 |
| EPS Growth(%) | -59.76 | 167.88 | 129.47 | 74.53 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 2.42 | 2.67 | 3.21 | 3.34 |
| Current Ratio(x) | 6.82 | 3.68 | 2.69 | 8.19 |
| Quick Ratio(x) | 6.82 | 3.68 | 2.69 | 8.19 |
| Interest Cover(x) | 1.26 | 1.65 | 1.91 | 2.12 |
| Total Debt/Mcap(x) | 0.84 | 0.79 | 1.12 | 0.95 |
SHARE HOLDING PATTERN FOR CREDITACCESS GRAMEEN LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| FII % | 8.67 | 9.33 | 9.60 | 9.67 | 9.55 | 11.46 | 12.00 | 11.65 | 10.88 | 10.76 |
| DII % | 0.08 | 0.14 | 0.14 | 0.12 | 0.13 | 0.14 | 0.20 | 0.30 | 0.31 | 0.27 |
| Public % | 6.76 | 4.25 | 4.16 | 4.37 | 11.77 | 6.08 | 5.55 | 6.01 | 6.31 | 7.83 |
PEER COMPARISON FOR CREDITACCESS GRAMEEN LIMITED
CORPORATE ACTIONS FOR CREDITACCESS GRAMEEN
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 15-Oct-2024 | Board Meeting - Quarterly Results | 25-Oct-2024 |
| BSE 10-Jul-2024 | Board Meeting - Quarterly Results | 19-Jul-2024 |
| BSE 09-Jul-2024 | Book Closure - A.G.M. | 27-Jul-2024 12-Aug-2024 |
| BSE 09-Jul-2024 | AGM - A.G.M. | 12-Aug-2024 12-Aug-2024 |
| BSE 07-May-2024 | Dividend - Rs.10.0000 per share(100%)Final Dividend | |
| BSE 02-May-2024 | Board Meeting - Audited Results & Final Dividend | 07-May-2024 |
| BSE 22-Apr-2024 | Board Meeting - Audited Results | 07-May-2024 |
| BSE 02-Jan-2024 | Board Meeting - Quarterly Results & Inter alia, to consider a Proposal of raising funds through Public Issue of Non-Convertible Debentures in domestic market, in one or more tranches up to such Shelf limit, as may be decided by the Board of Directors. | 19-Jan-2024 |
| BSE 04-Oct-2023 | Board Meeting - Quarterly Results | 20-Oct-2023 |
| BSE 10-Jul-2023 | Board Meeting - Quarterly Results | 21-Jul-2023 |
| BSE 16-May-2023 | Board Meeting - Audited Results | 16-May-2023 |
| BSE 03-May-2023 | Board Meeting - Audited Results | 16-May-2023 |
| BSE 27-Jan-2023 | Board Meeting - Quarterly Results | 07-Feb-2023 |
| BSE 11-Oct-2022 | Board Meeting - Quarterly Results | 21-Oct-2022 |
| BSE 13-Jul-2022 | Board Meeting - Quarterly Results | 29-Jul-2022 |
| BSE 04-May-2022 | Board Meeting - Audited Results | 12-May-2022 |
| BSE 15-Mar-2022 | Board Meeting - Inter alia, to consider and approve the proposal of raising funds through public issue of Non-Convertible Debentures in domestic market, in one or more tranches up to such Shelf limit, as may be decided by the Directors. | 23-Mar-2022 |
| BSE 14-Feb-2022 | Board Meeting - Inter alia, to consider and approve the proposal of issuance of Rupee Denominated, Non-Convertible Bonds. | 16-Feb-2022 |
| BSE 24-Jan-2022 | Board Meeting - Quarterly Results | 04-Feb-2022 |
| BSE 25-Oct-2021 | Board Meeting - Quarterly Results | 09-Nov-2021 |
CORPORATE ANNOUNCEMENTS FOR CREDITACCESS GRAMEEN
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 29-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of Earning Call held on October 25 2024 for Q2 FY25 Results. |
| BSE 29-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of schedule of Investor Call. |
| BSE 28-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Call |
| BSE 26-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication for Unaudited Financial Results for the quarter and half year ended September 30 2024 |
| BSE 26-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Audio Recording for Q2FY25 Results Conference Call |
| BSE 25-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 Amended Code of Conduct under the SEBI (PIT) Regulations 2024 |
| BSE 25-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release for Q2 FY25 results |
| BSE 25-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation for quarter and half year ended September 30 2024 |
| BSE 25-Oct-2024 | Outcome FILE | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2024 Outcome of Board Meeting held on October 25 2024 |
| BSE 25-Oct-2024 | Outcome FILE | Board Meeting Outcome for Unaudited Financial Statement For The Quarter And Half Year Ended September 30 2024 Outcome of the Board Meeting held on October 25 2024 |
| BSE 24-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Intimation of allotment of Equity Shares under Employee Stock Option Plan of the Company |
| BSE 21-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Q2 FY25 results conference call with Investors and Analysts. |
| BSE 15-Oct-2024 | Intimation FILE | Board Meeting Intimation for Considering Unaudited Financial Result For The Quarter And Half Year Ended On September 30 2024 Creditaccess Grameen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve unaudited financial result for the quarter and half year ended on September 30 2024 |
| BSE 10-Oct-2024 | General Announcements FILE | Key Business Update Intimation of Key Business Update for the quarter ended September 30 2024 |
| BSE 07-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Intimation of Allotment of Equity Shares under the Employee stock option plan of the Company |
| BSE 07-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2024 |
| BSE 03-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Meeting |
| BSE 27-Sep-2024 | Intimation FILE | Closure of Trading Window Intimation of Closure of Trading Window |
| BSE 26-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Meetings scheduled on September 26 & 27 2024 and October 03 2024 |
| BSE 24-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Intimation of Allotment of Equity Shares under Employee Stock Option plan of the Company |
| BSE 17-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investors call. |
| BSE 16-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investors call. |
| BSE 06-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release |
| BSE 06-Sep-2024 | General Announcements FILE | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Chief Financial Officer Intimation of the appointment of Mr. Nilesh Dalvi as the Chief Financial Officer (KMP) of the Company. |
| BSE 04-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of Equity Shares under the Employee Stock Option Plan of the Company. |
| BSE 02-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investors Meetings schedule. |
| BSE 30-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of schedule of Investor meeting. |
| BSE 28-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Meeting |
| BSE 23-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Meeting |
| BSE 23-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Call |
INSIDER TRADING FOR CREDITACCESS GRAMEEN
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 16-Feb-2022 17-Feb-2022 | Sell Market | 1,770 @ 0.00 (0.01 %) | HARIDARSHINI A |
| BSE 08-Feb-2022 08-Feb-2022 | Sell Market | 3,000 @ 0.00 (0.00 %) | PIYUSH SARAOGI |
| BSE 10-Feb-2022 11-Feb-2022 | Sell Market | 2,036 @ 0.00 (0.00 %) | HARIDARSHINI A |
| BSE 08-Feb-2022 08-Feb-2022 | Sell Market | 5,000 @ 0.00 (0.00 %) | LOKESH M K |
| BSE 09-Feb-2022 09-Feb-2022 | Sell Market | 500 @ 0.00 (0.00 %) | HARIDARSHINI A |
| BSE 07-Feb-2022 11-Feb-2022 | Sell Market | 15,765 @ 0.00 (0.01 %) | SRIVATSA H N |
| BSE 10-Feb-2022 10-Feb-2022 | Sell Market | 35,660 @ 0.00 (0.03 %) | UDAYA KUMAR HEBBAR |
| BSE 07-Feb-2022 07-Feb-2022 | Sell Market | 3,538 @ 0.00 (0.00 %) | HARIDARSHINI A |
| BSE 29-Dec-2021 29-Dec-2021 | Sell Market | 5,199 @ 0.00 (0.00 %) | UDAYA KUMAR HEBBAR |
| BSE 15-Dec-2021 15-Dec-2021 | Sell Market | 29,180 @ 0.00 (0.02 %) | UDAYA KUMAR HEBBAR |
| BSE 08-Sep-2021 08-Sep-2021 | Sell Market | 2,000 @ 0.00 (0.00 %) | MANJUNATHA |
| BSE 27-Aug-2021 27-Aug-2021 | Sell Market | 2,000 @ 0.00 (0.00 %) | Reshma Mehaboob |
BULK BLOCK DEALS FOR CREDITACCESS GRAMEEN LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 17-Oct-2022 | Sell BLOCK | 113,604 @ 977.15 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 17-Oct-2022 | Buy BLOCK | 113,604 @ 977.15 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 17-Oct-2022 | Sell BLOCK | 16,347 @ 977.15 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 17-Oct-2022 | Buy BLOCK | 16,347 @ 977.15 | ISHARES MSCI INDIA SMALL-CAP ETF |
| BSE 11-Oct-2022 | Sell BLOCK | 109,546 @ 995.65 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 11-Oct-2022 | Buy BLOCK | 109,546 @ 995.65 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 11-Oct-2022 | Sell BLOCK | 15,762 @ 995.65 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 11-Oct-2022 | Buy BLOCK | 15,762 @ 995.65 | ISHARES MSCI INDIA SMALL-CAP ETF |
| BSE 19-Sep-2022 | Sell BLOCK | 101,683 @ 1012.65 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 19-Sep-2022 | Buy BLOCK | 101,683 @ 1012.65 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 19-Sep-2022 | Sell BLOCK | 14,494 @ 1012.65 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 19-Sep-2022 | Buy BLOCK | 14,494 @ 1012.65 | ISHARES MSCI INDIA SMALL-CAP ETF |
SPLIT / BONUS BY CREDITACCESS GRAMEEN LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
